Episode #120: CCCC Stock Breakdown

Confessions Of A Market Maker

JJ breaks down the company C4 Therapeutics (CCCC) fresh off its new deal with Merck. Drawing from his previous experience running deals, JJ informs the listeners on what to look out for if you plan to play this ticker or one similar. Looking past the catchy headlines, you'll learn to let the chart tell you the real story.

---------------------------------------------------------------------------------------------

Any listener of this podcast that has the skills to pass an evaluation can become a prop trader fully funded by either APEX Trader or Topstep Funding. Our own microefutures trading community has many members who are now fully funded; no need to trade with your own money; keep 90% of your profits. To learn more, visit our website at https://microefutures.com/

---------------------------------------------------------------------------------------------

JJ on Twitter: https://twitter.com/vwaptrader1

Ray on Twitter: https://twitter.com/AllxDayxRayx